NovaBridge Biosciences (NBP) Assets Average (2020 - 2025)

NovaBridge Biosciences (NBP) has reported Assets Average for 6 consecutive years, with $269.0 million the latest figure, recorded in Q4 2025.

• Quarterly Assets Average rose 20.79% year-over-year to $269.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $269.0 million (up 20.79% YoY) and the FY2025 annual result came in at $236.6 million, down 18.66% from the prior year.
• Assets Average advanced to $269.0 million in Q4 2025 per NBP's latest filing, from $242.1 million in the prior quarter.
• Over the last five years, Assets Average for NBP reached as high as $954.0 million in Q2 2021 and fell as low as $207.8 million in Q2 2025.
• A 5-year average of $478.4 million and a median of $269.0 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average surged 255.62% — and 2023, when it sank 34.8%.
• Year by year, Assets Average stood at $914.1 million in 2021, then declined by 27.91% to $659.0 million in 2022, then fell by 19.8% to $528.5 million in 2023, then tumbled by 57.87% to $222.7 million in 2024, then advanced by 20.79% to $269.0 million in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $269.0 million, $242.1 million, and $207.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.